780
A. A. Fadda, H. A. Etman, M. Y. El-Seidy, and K. M. Elattar
Vol 49
afford 22 as dark red crystals (81%). m.p.: 167ꢀC; IR (KBr):
2573 (2SH), 1639 (CO), 1494 (N═N); 1H-NMR (400 MHz,
DMSO-d6): d, 1.58–1.68 (m, 6H, 3CH2, piperidine), 2.42
(s, 3H, CH3), 3.09 (s, 3H, N―CH3), 3.55–3.65 (m, 4H,
2CH2, piperidine), 7.17–7.52 (m, 7H, Ar-H, 2SH); ms:
(m/z, %): 438 (M+-3, 0.5), 342 (13.1), 187 (100.0), 144 (5.4),
121 (25.8), 88 (44.0), 56 (49.2). Anal. Calcd. for C20H23N7OS2
(441.57): C, 54.40; H, 5.25; N, 22.20%. Found: C, 54.51; H,
5.28; N, 22.27%.
6.93–7.51 (m, 5H, Ar-H), 10.81 (br, s, 2H, 2NH), ms:
(m/z, %): 503 (M+, 0.41), 286 (70.0), 271 (22.34), 229 (9.16),
200 (38.0), 168 (17.04), 86 (100.0), 77 (62.9). Anal. calcd for
C25H26N8O2S (502.59): C, 59.74; H, 5.21; N, 22.30%. Found:
C, 59.81; H, 5.29; N, 22.37%.
4-{6-Amino-4-[methyl-(2,3,4,5,6-pentahydroxy-hexyl)-amino]-
1-phenyl-2-thioxo-1,2-dihydro-pyrimidin-5-ylazo}-1,5-dimethyl-
2-phenyl-1,2-dihydro-pyrazol-3-one (25c). Yield (60%). m.p.
187ꢀC; IR (KBr) ύ (cmꢁ1), 3453, 3446 (OH), 3109 (NH),
2962 (C―H, stretching), 1658 (CO), 1446 (N═N), 1230
Synthesis of [2-cyano-2-(1,5-dimethyl-3-oxo-2-phenyl-
2,3-dihydro-1H-pyrazol-4-ylazo)-1-piperidin-1-yl-vinyl]-
1
(C═S); H-NMR (400 MHz, DMSO-d6): d, 2.47 (s, 3H, CH3),
3.16 (s, 3H, N―CH3), 3.01–4.52 (sugar moiety protons),
7.15–7.65 (m, 5H, Ph), 11.12 (br., s, 2H, 2NH); ms: (m/z, %):
590 [(M+-2)-H2O, 4.3], 589 (M+-3-H2O, 5.2), 181 (48.3), 136
(50.0), 93 (100.0), 51 (87.9). Anal. calcd for C28H34N8O6S
(610.68): C, 55.07; H, 5.61; N, 18.35%. Found: C, 55.13; H,
5.66; N, 18.40%.
dithiocarbamic acid methyl ester (24).
To a vigorously
stirred solution of enaminonitrile 3 (7.35 g, 0.02 mol) in
dimethylformamide (10 mL) at room temperature, carbon
disulphide (1.57 mL, 0.026 mol) and aqueous sodium hydroxide
(1.2 mL, 20 mol solution) were added simultaneously over
30 min. Stirring was continued for a further 30 min. Dimethyl
sulphate (1.9 mL g, 0.02 mol) was added dropwise to the
reaction mixture with stirring at 5–10ꢀC; it was further stirred
for 3 h and poured into ice-water; the solid obtained was
filtered, dried, and recrystallized from ethanol to afford 24 as
orange powder (88%). m.p. 152ꢀC; IR (KBr) cmꢁ1: 3151
(NH), 2173 (CN), 1641 (C═O), 1494 (N═N), 1178 (C═S);
1H-NMR (400 MHz, DMSO-d6): d, 1.59–1.71 (m, 6H, 3CH2,
piperidine), 2.44 (s, 3H, CH3), 2.91 (s, 3H, SCH3), 3.10
(s, 3H, N―CH3), 3.56–3.64 (m, 4H, 2CH2, piperidine),
7.15–7.50 (m, 5H, Ar-H), 7.97 (br, s, 1H, NH), ms: (m/z, %):
455 (M+, 29.6), 384 (30.4), 288 (24.2), 239 (60.1), 188 (43.5),
175 (57.8), 144 (47.8), 84 (78.8), 70 (45.2). Anal. calcd for
C21H25N7OS2 (455.60): C, 55.36; H, 5.53; N, 21.52%. Found:
C, 55.41; H, 5.58; N, 21.61%.
Synthesis of 4-((4-amino-5-benzoyl-6-(4-chlorophenyl)-2-
morpholinopyridin-3-yl)diazenyl)-1,5-dimethyl-2-phenyl-1H-
pyrazol-3(2H)-one (27). A mixture of 4 (1.85 g, 5 mmol) and
3-(4-chloro-phenyl)-1-phenyl-propenone (1.21 g, 5 mmol) in
DMF-EtOH mixture (15 mL, 1:3) in the presence of catalytic
amount of triethylamine (5 drops) was refluxed for 15 h. The
reaction mixture was poured into ice cold water, the formed solid
product was filtered, dried, and crystallized from DMF-EtOH
(1:4) to yield 27 as dark brown powder (67%). m.p.: 118–120ꢀC;
IR (KBr) ύ (cmꢁ1), 3388, 3346 (NH2), 1683, 1637 (2CO), 1493
1
(N═N); H-NMR (400 MHz, DMSO-d6): d, 2.43 (s, 3H, CH3),
3.17 (s, 3H, N―CH3), 3.55–3.93 (m, 8H, 4CH2, morpholine),
7.05–8.35 (m, 16H, Ar-H, NH2); ms: (m/z, %): 617 (M++7, 1.6),
342 (24.9), 241 (100.0), 215 (36.7), 177 (34.7), 136 (19.5), 114
(10.8), 99 (42.0), 73 (93.7). Anal. Calcd. for C33H30ClN7O3
(608.09): C, 65.18; H, 4.97; N, 16.12%. Found: C, 65.24; H,
5.03; N, 16.17%.
Synthesis of 4-(2-(4-(substituted)-6-imino-1-phenyl-2-
thioxotetrahydro-pyrimidin-5(6H)-ylidene)hydrazinyl)-1,5-
dimethyl-2-phenyl-1H-pyrazol-3(2H)-ones (25a–c). An equimolar
mixture of 3 (1.84 g, 5 mmol) or 4 (1.85 g, 5 mmol) or 5
(2.39 g, 5 mmol) and phenyl isothiocyanate (0.6 mL, 5
mmol) in EtOH-DMF mixture (3:1, 20 mL) in the presence
of catalytic amount of TEA (four drops) was refluxed for 21
h. The reaction mixture was left to cool and poured into
cold water for complete precipitation. The separated solid
was filtered off, washed with water, dried well, and
recrystallized from ethanol to yield pyrimidine derivatives
25a–c.
REFERENCES AND NOTES
[1] Fadda, A. A.; Bondock, S.; Rabie, R.; Etman, H. A. Eur J Med
Chem 2008, 43, 2122.
[2] Abdel-Latif, E. Phosphorus Sulfur Silicon Relat Elem 2006,
181, 125.
[3] Fadda, A. A.; Bondock, S.; Rabie, R. Monatsheft Chem 2008,
139, 153.
[4] Carciunescu, D. G. An R Acad Farm 1977, 43, 265.
[5] McCrea, J. B.; Vlasses, P. H.; Rocci, M. L., Jr. Ann Pharmacother
1989, 23, 38.
[6] Meffin, P. J.; Williams, R. L.; Blaschke, T. F.; Rowland, M. J
Pharm Sci 1977, 66, 135.
[7] Wensing, G.; Neumann, U.; Ohnhaus, E. E.; Heidemann, H. T.
Clini Pharmacol Ther 1990, 48, 575.
[8] Jain, S. C.; Sinha, J.; Bhagat, S.; Errington, W.; Olsen, C. E.
Synth Commun 2003, 33, 563.
[9] Cechinel, F. V.; Correa, R.; Vaz, Z.; Calixto, J. B.; Nunes,
R. J.; Pinheiro, T. R.; Andricopulo, A. D.; Yunes, R. A. Farmaco
1998, 53, 55.
4-(6-Amino-1-phenyl-4-piperidin-1-yl-2-thioxo-1,2-dihydro-
pyrimidin-5-ylazo)-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-
3-one (25a).
Yield (50%). m.p. 157ꢀC; IR (KBr) ύ (cmꢁ1),
3193 (NH), 2964 (C―H, stretching), 1643 (CO), 1452 (N═N),
1
1216 (C═S); H-NMR (400 MHz, DMSO-d6): d, 1.55–1.67 (m,
6H, 3CH2, piperidine), 2.61 (s, 3H, CH3), 3.22 (s, 3H, N―CH3),
3.53–3.66 (m, 4H, 2CH2, piperidine), 7.38–7.56 (m, 5H, Ph),
10.86 (br, s, 2H, 2NH); ms: (m/z, %): 500 (M+, 0.21), 284 (9.13),
283 (8.57), 227 (8.13), 200 (7.77), 109 (13.5), 84 (100.0), 77
(90.0). Anal. calcd for C26H28N8OS (500.62): C, 62.38; H, 5.64;
N, 22.38%. Found: C, 62.46; H, 5.74; N, 22.43%.
4-(6-Amino-4-morpholin-4-yl-1-phenyl-2-thioxo-1,2-dihydro-
pyrimidin-5-ylazo)-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-
3-one (25b). Yield (57%). m.p. 193ꢀC; IR (KBr) ύ (cmꢁ1),
3183 (NH), 2958 (C―H, stretching), 1647 (CO), 1462
(N═N), 1209 (C═S); 1H-NMR (400 MHz, DMSO-d6): d,
2.24–2.29 (m, 4H, 2CH2, morpholine), 2.43 (s, 3H, CH3), 3.17
(s, 3H, N―CH3), 3.34–3.71 (m, 4H, 2CH2, morpholine),
[10] Sondhi, S. M.; Sharma, V. K.; Verma, R. P.; Singhal, N.;
Shukla, R.; Raghubir, R.; Dubey, M. P. Synthesis 1999, 878.
[11] Mishra, A. P. J Indian Chem Soc 1999, 76, 35.
[12] Raman, N.; Kulandaisamy, A.; Jeyasubramanian, K. Syn
React Inorg Met 2002, 32, 1583.
[13] Raman, N.; Kulandaisamy, A.; Jeyasubramanian, K. Syn
React Inorg Met 2004, 34, 17.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet